TY  - GEN
AU  - Yang,Fu-Qiang
AU  - Rao,Gui-Rong
AU  - Wang,Gui-Qiang
AU  - Li,Yue-Qi
AU  - Xie,Yao
AU  - Zhang,Zhan-Qing
AU  - Deng,Cun-Liang
AU  - Mao,Qing
AU  - Li,Jun
AU  - Zhao,Wei
AU  - Wang,Mao-Rong
AU  - Han,Tao
AU  - Chen,Shi-Jun
AU  - Pan,Chen
AU  - Tan,De-Ming
AU  - Shang,Jia
AU  - Zhang,Ming-Xiang
AU  - Zhang,Yue-Xin
AU  - Yang,Ji-Ming
AU  - Chen,Guang-Ming
TI  - Phase IIb trial of 
SN  - 2219-2840
PY  - 2017///0717
KW  - Adult
KW  - DNA, Viral
KW  - administration & dosage
KW  - Double-Blind Method
KW  - Drug Resistance, Viral
KW  - drug effects
KW  - Electroporation
KW  - methods
KW  - Female
KW  - Hepatitis B Vaccines
KW  - Hepatitis B virus
KW  - genetics
KW  - Hepatitis B, Chronic
KW  - drug therapy
KW  - Humans
KW  - Injections, Intramuscular
KW  - Lamivudine
KW  - Male
KW  - Plasmids
KW  - Reverse Transcriptase Inhibitors
KW  - Treatment Outcome
KW  - Vaccines, DNA
KW  - Viral Load
KW  - Young Adult
N1  - Publication Type: Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial
UR  - https://doi.org/10.3748/wjg.v23.i2.306
ER  -